Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acorda Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (39)	8/5/2009 7:22:30 AM
From: kenhott	Read Replies (1) \| Respond to of 120

The fear is that somehow the drug is making the disease progress with LT use. I don't see that... with the current info. And the drug's mode of action would not normally point directly to such a risk. Or maybe there is a rebound effect after stopping the drug. IF there is a rebound effect, it seems to me to be a short term issue only. I would have to agree that if one is interested in holding the stock into the FDA decision, this maybe the low prior to those events. The next point is the Adv Mtg, the date of which has yet to be confirmed but tentatively scheduled for Sept 22nd.